CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature.
CPX-351
acute myeloid leukemia
acute promyelocytic leukemia
allogeneic hematopoietic stem cell transplantation
therapy-related myeloid neoplasm
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
09
2023
accepted:
28
12
2023
medline:
9
2
2024
pubmed:
9
2
2024
entrez:
9
2
2024
Statut:
epublish
Résumé
Therapy-related myeloid neoplasms (t-MNs), which develop after cytotoxic, radiation, or immunosuppressive therapy for an unrelated disease, account for 7%-8% of acute myeloid leukemia (AML). Worse outcomes and consequently shortened survival are associated with t-MNs as compared with
Identifiants
pubmed: 38333543
doi: 10.3389/fonc.2023.1291457
pmc: PMC10850225
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1291457Informations de copyright
Copyright © 2024 Sperotto, Stanghellini, Peccatori, De Marchi, Piemontese, Ciotti, Basso, Pierdomenico, Fiore, Ciceri and Gottardi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.